Tislelizumab

8 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Tislelizumab
Treatment and conditionWhere it standsTrials
Tislelizumab for adenocarcinoma of lungPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tislelizumab for carcinoma, transitional cellPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tislelizumab for cholangiocarcinomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tislelizumab for mesotheliomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tislelizumab for neoplasms, unknown primaryPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tislelizumab for sarcomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tislelizumab for squamous cell carcinoma of head and neckPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)3
Tislelizumab for uterine cervical neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1